Barriers to HIV/AIDS Treatment in Nigeria

Jalal-Eddeen Abubakar Saleh; Haruna Ismaila Adamu

doi:doi:10.11648/j.ajhr.20150305.17

| Peer-Reviewed

Barriers to HIV/AIDS Treatment in Nigeria

Jalal-Eddeen Abubakar Saleh, Haruna Ismaila Adamu

Published in American Journal of Health Research (Volume 3, Issue 5)

Received: 23 August 2015 Accepted: 7 September 2015 Published: 14 September 2015

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Background: With the exception of South Africa and India, the number people living with Human Immunodeficiency Virus (PLWHA) in Nigeria exceeds that of any other country in the World. Access to HIV/AIDS treatment services remains a challenge as only 6% of PLWHAs have accessed the services. This stands in the way of achieving the National HIV/AIDS policy as well as the global goal of placing 15 million PLWHAs on treatment and care by the end of the year 2015. In order to achieve these goals, there is need to know the barriers (through systematic literature review) that prevent access to HIV/AIDS treatment especially in the developing world of sub-Saharan Africa (of which Nigeria is among) that houses 70% of global HIV/AIDS burden. When these barriers are known, strategies would then be adopted to remove them so as to improve the treatment coverage. Study Design: Systematic review. Methods: Twenty studies looking at issues surrounding barriers preventing access to HIV/AIDS treatment and support services in Nigeria and other developing countries were reviewed in order to identify key issues or barriers militating against the smooth delivery of HIV/AIDS treatment services and recommend strategies for removing them in order to achieve the much desired universal access to HIV treatment. Results: Suggest that the barriers to HIV/AIDS treatment in the developing world are grouped into three categories namely health systems related, patients related and community related. Conclusion: Sequel to the literature review findings, stakeholders must come together and agree on a sustainable and community driven approach to HIV/AIDS treatment in Nigeria.

Published in	American Journal of Health Research (Volume 3, Issue 5)
DOI	10.11648/j.ajhr.20150305.17
Page(s)	305-309
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2015. Published by Science Publishing Group

Keywords

HIV, AIDS, ARV, ART, Barriers, Nigeria, Sub-saharan Africa, Low-Mid Income Countries

References

[1]	Aliyu, M., Varkey, P., Salihu, H., Iliyasu, Z., & Abubakar, I. (2010). The HIV/AIDS epidemic in Nigeria: progress, problems and prospects. Afr J Med Med Sci.39 (3): 233-9. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21416794.
[2]	CDC (2015). HIV Basics. Retrieved from http://www.cdc.gov/hiv/basics/index.html.
[3]	UNAIDS (2014). AIDS and Global Health. Retrieved from data.unaids.org/pub/Report/2009/aidsandglobalhealth_en.pdf.
[4]	WHO (2015a). HIV/AIDS Fact sheet N°360. Retrieved from http://www.who.int/mediacentre/factsheets/fs360/en/.
[5]	WHO (2015b). Global Health Observatory (GHO) data. Retrieved from http://www.who.int/gho/hiv/epidemic_response/ART_text/en/.
[6]	Federal Ministry of Health [Nigeria] (2013). National HIV & AIDS and Reproductive Health Survey, 2012 (NARHS Plus). Federal Ministry of Health Abuja, Nigeria. Retrieved from https://www.academia.edu/9469489/NARHS_Plus_2012_Final_18112013.
[7]	Undata (2015). Nigeria Profile. Retrieved from https://data.un.org/CountryProfile.aspx?crName=NIGERIA.
[8]	UNFPA Nigeria (2015). National Policy on HIV/AIDS. Retrieved from http://nigeria.unfpa.org/pdf/ntpol.pd.
[9]	Lule, E. & Haacker, M. (2012). The fiscal dimension of HIV/AIDS in Botswana, South Africa, Swaziland and Uganda. The World Bank. Retrieved from http://www.avert.org/hiv-aids-sub-saharan-africa.htm#footnote49 ydy85ph.
[10]	Orsi, F., & d'almeida, C. (2010). Soaring antiretroviral prices, TRIPS and TRIPS flexibilities: a burning issue for antiretroviral treatment scale-up in developing countries. Curr Opin HIV AIDS 5(3):237-41. doi: 10.1097/COH.0b013e32833860ba. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20539080.
[11]	Hoen, E.’t, Berger, J., Calmy, A., & Moon, S. (2011). Driving a decade of change: HIV/AIDS, patents and access to medicines for all. Journal of the International AIDS Society, 14, 15. doi: 10.1186/1758-2652-14-15. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078828/.
[12]	Waning, B., Kyle, M., Diedrichsen, E., Soucy, L., Hochstadt, J., Bärnighausen, T., & Moon, S. (2010). Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets. Globalization and Health, 6, 9. doi: 10.1186/1744-8603-6-9. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883977/.
[13]	Waning, B., Diedrichsen, E., & Moon, S. (2010). A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries. J Int AIDS Soc.13:35. doi: 10.1186/1758-2652-13-35. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20840741.
[14]	Satyanarayana, K., & Srivastava, S. (2010). Patent Pooling for Promoting Access to Antiretroviral Drugs (ARVs) – A Strategic Option for India. The Open AIDS Journal, 4, 41–53. doi: 10.2174/1874613601004020041. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819698/.
[15]	Babovic, S. and Wasan, K. M. (2011). Impact of the trade-related aspects of intellectual property rights (TRIPS) agreement on India as a supplier of generic antiretrovirals. J. Pharm. Sci., 100: 816–821. doi: 10.1002/jps.22326. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20740678.
[16]	Wouters, E., Van Damme, W., van Rensburg, D., Masquillier, C., & Meulemans, H. (2012). Impact of community-based support services on antiretroviral treatment programme delivery and outcomes in resource-limited countries: a synthetic review. BMC Health Services Research, 12, 194. doi: 10.1186/1472-6963-12-194. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476429/.
[17]	Ford, N., Calmy, A., & Mills, E. J. (2011). The first decade of antiretroviral therapy in Africa. Globalization and Health, 7, 33. doi: 10.1186/1744-8603-7-33. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192657/.
[18]	Callaghan, M., Ford, N., & Schneider, H. (2010). A systematic review of task- shifting for HIV treatment and care in Africa. Human Resources for Health, 8, 8. doi: 10.1186/1478-4491-8-8. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873343/.
[19]	Decroo, T., Rasschaert, F., Telfer, B., Remartinez, D., Laga, M., & Ford, N. (2013). Community-based antiretroviral therapy programs can overcome barriers to retention of patients and decongest health services in sub-Saharan Africa: a systematic review. Int Health 5(3):169-79. doi: 10.1093/inthealth/iht016. Epub 2013 Jul 30.
[20]	Colvin, C. J., Konopka, S., Chalker, J. C., Jonas, E., Albertini, J., Amzel, A. et al. (2014). A Systematic Review of Health System Barriers and Enablers for Antiretroviral Therapy (ART) for HIV-Infected Pregnant and Postpartum Women. PLoS ONE 9(10): e108150. doi:10.1371/journal.pone.0108150. Retrieved from http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0108150.
[21]	Okoye, U. O., Diekedie, A., and Afemikhe, O. A. (2015). Perceived Barriers to Accessing and Adhering to Antiretroviral Therapy by People Living with HIV/AIDS (PLWHAs) in Akwa Ibom State, Nigeria. Research on Humanities and Social Sciences ISSN (Paper) 2224-5766 ISSN (Online) 2225-0484 (Online) Vol.5, No.9. Retrieved from www.iiste.org/Journals/index.php/RHSS/article/download/.../23242.
[22]	Chindedza, M., Mutseyekwa, F., Chideme-Munodawafa, A. (2013). Perceived barriers to accessing and achieving adherence in antiretroviral therapy among HIV patients at a rural mission hospital in Zimbabwe. European Scientific Journal vol.9, No.24 ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431. Retrieved from eujournal.org/index.php/esj/article/viewFile/1711/1700.
[23]	Hodgson, I., Plummer, M. L., Konopka, S. N., Colvin, C. J., Jonas, E. et al. (2014). A Systematic Review of Individual and Contextual Factors Affecting ART Initiation, Adherence, and Retention for HIV-Infected Pregnant and Postpartum Women. PLoS ONE 9(11): e111421. doi: 10.1371/journal.pone.0111421.
[24]	Beaulière, A., Le Maux, A., Trehin, C., & Perez, F. (2010). Access to antiretroviral treatment in developing countries: Which financing strategies are possible? Rev Epidemiol Sante Publique. 58(3):171-9. doi: 10.1016/j.respe.2010.03.002. Epub 2010 Apr 28. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20430553.
[25]	Ullah, A. K. M. (2011). HIV/AIDS-Related Stigma and Discrimination: A Study of Health Care Providers in Bangladesh. JIAPAC 10(2):97-104. Retrieved from http://www.avert.org/hiv-aids-sub-saharan-africa.htm#sthash.ePHsgEeT.dpuf.
[26]	Ellsberg, A. & Betron, M. (2010). Preventing Gender-Based Violence and HIV: Lessons from the Field. AIDSTAR-One: Spotlight on Gender. Retrieved from http://www.avert.org/hiv-aids-sub-saharan-africa.htm#sthash.ePHsgEeT.dpuf.
[27]	Seeling, S., Mavhunga, F., Thomas, A., Adelberger, B., & Ulrichs, T. (2014). Barriers to access to antiretroviral treatment for HIV-positive tuberculosis patients in Windhoek, Namibia. International Journal of Mycobacteriology Volume 3, Issue 4, Pages 268–275. Retrieved from http://www.sciencedirect.com/science/article/pii/S2212553114000685?np=y.
[28]	Peterson, M. J. (2010). “Access to HIV Treatments in Developing Countries.” International Dimensions of Ethics Education in Science and Engineering. Retrieved from www.umass.edu/sts/ethics.

Cite This Article

Plain Text BibTeX RIS

APA Style

Jalal-Eddeen Abubakar Saleh, Haruna Ismaila Adamu. (2015). Barriers to HIV/AIDS Treatment in Nigeria. American Journal of Health Research, 3(5), 305-309. https://doi.org/10.11648/j.ajhr.20150305.17

Copy | Download

ACS Style

Jalal-Eddeen Abubakar Saleh; Haruna Ismaila Adamu. Barriers to HIV/AIDS Treatment in Nigeria. Am. J. Health Res. 2015, 3(5), 305-309. doi: 10.11648/j.ajhr.20150305.17

Copy | Download

AMA Style

Jalal-Eddeen Abubakar Saleh, Haruna Ismaila Adamu. Barriers to HIV/AIDS Treatment in Nigeria. Am J Health Res. 2015;3(5):305-309. doi: 10.11648/j.ajhr.20150305.17

Copy | Download

@article{10.11648/j.ajhr.20150305.17,
  author = {Jalal-Eddeen Abubakar Saleh and Haruna Ismaila Adamu},
  title = {Barriers to HIV/AIDS Treatment in Nigeria},
  journal = {American Journal of Health Research},
  volume = {3},
  number = {5},
  pages = {305-309},
  doi = {10.11648/j.ajhr.20150305.17},
  url = {https://doi.org/10.11648/j.ajhr.20150305.17},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajhr.20150305.17},
  abstract = {Background: With the exception of South Africa and India, the number people living with Human Immunodeficiency Virus (PLWHA) in Nigeria exceeds that of any other country in the World. Access to HIV/AIDS treatment services remains a challenge as only 6% of PLWHAs have accessed the services. This stands in the way of achieving the National HIV/AIDS policy as well as the global goal of placing 15 million PLWHAs on treatment and care by the end of the year 2015. In order to achieve these goals, there is need to know the barriers (through systematic literature review) that prevent access to HIV/AIDS treatment especially in the developing world of sub-Saharan Africa (of which Nigeria is among) that houses 70% of global HIV/AIDS burden. When these barriers are known, strategies would then be adopted to remove them so as to improve the treatment coverage. Study Design: Systematic review. Methods: Twenty studies looking at issues surrounding barriers preventing access to HIV/AIDS treatment and support services in Nigeria and other developing countries were reviewed in order to identify key issues or barriers militating against the smooth delivery of HIV/AIDS treatment services and recommend strategies for removing them in order to achieve the much desired universal access to HIV treatment. Results: Suggest that the barriers to HIV/AIDS treatment in the developing world are grouped into three categories namely health systems related, patients related and community related. Conclusion: Sequel to the literature review findings, stakeholders must come together and agree on a sustainable and community driven approach to HIV/AIDS treatment in Nigeria.},
 year = {2015}
}

Copy | Download

TY  - JOUR
T1  - Barriers to HIV/AIDS Treatment in Nigeria
AU  - Jalal-Eddeen Abubakar Saleh
AU  - Haruna Ismaila Adamu
Y1  - 2015/09/14
PY  - 2015
N1  - https://doi.org/10.11648/j.ajhr.20150305.17
DO  - 10.11648/j.ajhr.20150305.17
T2  - American Journal of Health Research
JF  - American Journal of Health Research
JO  - American Journal of Health Research
SP  - 305
EP  - 309
PB  - Science Publishing Group
SN  - 2330-8796
UR  - https://doi.org/10.11648/j.ajhr.20150305.17
AB  - Background: With the exception of South Africa and India, the number people living with Human Immunodeficiency Virus (PLWHA) in Nigeria exceeds that of any other country in the World. Access to HIV/AIDS treatment services remains a challenge as only 6% of PLWHAs have accessed the services. This stands in the way of achieving the National HIV/AIDS policy as well as the global goal of placing 15 million PLWHAs on treatment and care by the end of the year 2015. In order to achieve these goals, there is need to know the barriers (through systematic literature review) that prevent access to HIV/AIDS treatment especially in the developing world of sub-Saharan Africa (of which Nigeria is among) that houses 70% of global HIV/AIDS burden. When these barriers are known, strategies would then be adopted to remove them so as to improve the treatment coverage. Study Design: Systematic review. Methods: Twenty studies looking at issues surrounding barriers preventing access to HIV/AIDS treatment and support services in Nigeria and other developing countries were reviewed in order to identify key issues or barriers militating against the smooth delivery of HIV/AIDS treatment services and recommend strategies for removing them in order to achieve the much desired universal access to HIV treatment. Results: Suggest that the barriers to HIV/AIDS treatment in the developing world are grouped into three categories namely health systems related, patients related and community related. Conclusion: Sequel to the literature review findings, stakeholders must come together and agree on a sustainable and community driven approach to HIV/AIDS treatment in Nigeria.
VL  - 3
IS  - 5
ER  -

Copy | Download

Author Information

Jalal-Eddeen Abubakar Saleh

World Health Organization, Bauchi Zonal Office, Bauchi State, Nigeria
Haruna Ismaila Adamu

World Health Organization, Bauchi Zonal Office, Bauchi State, Nigeria

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Jalal-Eddeen Abubakar Saleh, Haruna Ismaila Adamu. (2015). Barriers to HIV/AIDS Treatment in Nigeria. American Journal of Health Research, 3(5), 305-309. https://doi.org/10.11648/j.ajhr.20150305.17

Copy | Download

ACS Style

Jalal-Eddeen Abubakar Saleh; Haruna Ismaila Adamu. Barriers to HIV/AIDS Treatment in Nigeria. Am. J. Health Res. 2015, 3(5), 305-309. doi: 10.11648/j.ajhr.20150305.17

Copy | Download

AMA Style

Jalal-Eddeen Abubakar Saleh, Haruna Ismaila Adamu. Barriers to HIV/AIDS Treatment in Nigeria. Am J Health Res. 2015;3(5):305-309. doi: 10.11648/j.ajhr.20150305.17

Copy | Download

@article{10.11648/j.ajhr.20150305.17,
  author = {Jalal-Eddeen Abubakar Saleh and Haruna Ismaila Adamu},
  title = {Barriers to HIV/AIDS Treatment in Nigeria},
  journal = {American Journal of Health Research},
  volume = {3},
  number = {5},
  pages = {305-309},
  doi = {10.11648/j.ajhr.20150305.17},
  url = {https://doi.org/10.11648/j.ajhr.20150305.17},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajhr.20150305.17},
  abstract = {Background: With the exception of South Africa and India, the number people living with Human Immunodeficiency Virus (PLWHA) in Nigeria exceeds that of any other country in the World. Access to HIV/AIDS treatment services remains a challenge as only 6% of PLWHAs have accessed the services. This stands in the way of achieving the National HIV/AIDS policy as well as the global goal of placing 15 million PLWHAs on treatment and care by the end of the year 2015. In order to achieve these goals, there is need to know the barriers (through systematic literature review) that prevent access to HIV/AIDS treatment especially in the developing world of sub-Saharan Africa (of which Nigeria is among) that houses 70% of global HIV/AIDS burden. When these barriers are known, strategies would then be adopted to remove them so as to improve the treatment coverage. Study Design: Systematic review. Methods: Twenty studies looking at issues surrounding barriers preventing access to HIV/AIDS treatment and support services in Nigeria and other developing countries were reviewed in order to identify key issues or barriers militating against the smooth delivery of HIV/AIDS treatment services and recommend strategies for removing them in order to achieve the much desired universal access to HIV treatment. Results: Suggest that the barriers to HIV/AIDS treatment in the developing world are grouped into three categories namely health systems related, patients related and community related. Conclusion: Sequel to the literature review findings, stakeholders must come together and agree on a sustainable and community driven approach to HIV/AIDS treatment in Nigeria.},
 year = {2015}
}

Copy | Download

TY  - JOUR
T1  - Barriers to HIV/AIDS Treatment in Nigeria
AU  - Jalal-Eddeen Abubakar Saleh
AU  - Haruna Ismaila Adamu
Y1  - 2015/09/14
PY  - 2015
N1  - https://doi.org/10.11648/j.ajhr.20150305.17
DO  - 10.11648/j.ajhr.20150305.17
T2  - American Journal of Health Research
JF  - American Journal of Health Research
JO  - American Journal of Health Research
SP  - 305
EP  - 309
PB  - Science Publishing Group
SN  - 2330-8796
UR  - https://doi.org/10.11648/j.ajhr.20150305.17
AB  - Background: With the exception of South Africa and India, the number people living with Human Immunodeficiency Virus (PLWHA) in Nigeria exceeds that of any other country in the World. Access to HIV/AIDS treatment services remains a challenge as only 6% of PLWHAs have accessed the services. This stands in the way of achieving the National HIV/AIDS policy as well as the global goal of placing 15 million PLWHAs on treatment and care by the end of the year 2015. In order to achieve these goals, there is need to know the barriers (through systematic literature review) that prevent access to HIV/AIDS treatment especially in the developing world of sub-Saharan Africa (of which Nigeria is among) that houses 70% of global HIV/AIDS burden. When these barriers are known, strategies would then be adopted to remove them so as to improve the treatment coverage. Study Design: Systematic review. Methods: Twenty studies looking at issues surrounding barriers preventing access to HIV/AIDS treatment and support services in Nigeria and other developing countries were reviewed in order to identify key issues or barriers militating against the smooth delivery of HIV/AIDS treatment services and recommend strategies for removing them in order to achieve the much desired universal access to HIV treatment. Results: Suggest that the barriers to HIV/AIDS treatment in the developing world are grouped into three categories namely health systems related, patients related and community related. Conclusion: Sequel to the literature review findings, stakeholders must come together and agree on a sustainable and community driven approach to HIV/AIDS treatment in Nigeria.
VL  - 3
IS  - 5
ER  -

Copy | Download